Clinical implications of our findings are relevant for breast cancer, since inhibition of Pin1 could suppress aggressive phenotypes through CSC exhaustion as well as recovered sensitivity to chemotherapeutic drugs. This evidence concerns the gene PIN1 and breast cancer.